Aktivne farmacevtske sestavine
Progestogen in estrogen | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Progesteron | CP/EP/USP/JP | CEP/EU-GMP/FDA | 57-83-0 |
Menenolon | Notranja |
Košer | 145-13-1 |
Medroxyprogesteron Acetat | CP/EP/USP/JP | DMF/GMP | 71-58-9 |
Megerol acetat | CP/EP/USP | DMF v postopku | 595-33-5 |
Mifepriston | Cp/ip | DMF/GMP | 84371-65-3 |
Ciproteron acetat | CP/EP/IP/KP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP/IP | CEP/GMP | 797-63-7 |
Norethisterone |
CP/EP/USP/JP |
DMF v postopku |
68-22-4 |
Norethisterone acetat |
EP/USP |
DMF v postopku |
51-98-9 |
Norethisterone enanthat |
Notranja |
Pod raziskavo in razvoj |
3836-23-5 |
Drospirenon | EP/USP | DMF | 67392-87-4 |
Gestoden | CP/EP | DMF/GMP | 60282-87-3 |
Estradiol | CP/EP/USP/KP | DMF/GMP/WC | 35380-71-3 |
Estriol | CP/EP/USP | Pod raziskavo in razvoj | 50-27–1 |
Etinilni estradiol | CP/EP/USP | GMP | 57-63-6 |
Estradiol valerat | CP/EP/USP/KP | DMF | 979-32-8 |
Estradiol cipionat |
USP | DMF v postopku |
313-06-4 |
Tubulon | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | Ep | CEP/GMP | 65928-58-7 |
Fulvestrant | EP/USP | Pod raziskavo in razvoj | 129453-61-8 |
Exemestane | CP/EP/USP | Pod raziskavo in razvoj | 107868-30-4 |
Androgen | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Finasterid | CP/EP/USP | CEP / FDA / PMDA / GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abirateron acetat | CP/USP | DMF/WC | 154229-18-2 |
Darolutami |
Notranja |
Pod raziskavo in razvoj |
1297538-32-9 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosteron undecanoat | Cp | DMF/WC | 5949-44-0 |
Testosteron cipionat | USP | Pod raziskavo in razvoj | 58-20-8 |
Testosteron enanthat |
USP/JP | Pod raziskavo in razvoj |
315-37-7 |
Testosteron propionat |
CP/EP/USP/JP |
Pod raziskavo in razvoj |
57-85-2 |
DHEA (praces) | Fp/Notranja | DMF/WC/Kosher | 53-43-0 |
Claskoteron | Notranja | DMF v postopku | 19608-29-8 |
Kortikalni hormon | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Budesonide | CP/EP/USP/JP | CEP/FDA/GMP | 51333-22-3 |
Deson | CP/USP | DMF/GMP | 638-94-8 |
Eplerenone | Ep | CEP v postopku | 107724-20-9 |
Metilprednizolon | CP/EP/USP/JP | DMF/GMP | 83-43-2 |
Metilprednizolon Hemisukcinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
Flutikazon propionat | CP/EP/USP | DMF | 80474- 14-2 |
Fluticazon bes | CP/EP | DMF v postopku | 397864-44-7 |
Mometasone furoate |
CP/EP/USP |
DMF v postopku |
Brezvodni (83919-23-7) Monohidrat (141646-00-6) |
Deflazakort |
Notranja |
Pod raziskavo in razvoj |
14484-47-0 |
Drugi | |||
Ime izdelka | Specifikacija | Odobreno | Cas št. |
Oxcarbazepin | CP/EP/USP/IP | CEP/FDA/GMP | 28721-07-5 |
Eslicarbazepin acetat | CP/USP | DMF | 236395- 14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hidroklorid | USP/EP | CEP v postopku | 175865-59-5 |
Osetamivir fosfat | CP/EP/USP | DMF | 204255- 11-8 |
Baloxavir Marboxil | Notranja | Pod raziskavo in razvoj | 1985606-14-1 |
Revefenacin | Notranja | DMF | 864750-70-9 |
Mirabegron | CP/EP | DMF | 223673-61-8 |
Vibegron |
Notranja |
Pod raziskavo in razvoj |
1190389-15-1 |
Escitalopram oksalat | CP/EP/USP | DMF v postopku | 219861-08-2 |
Citalopram hidrobromid |
CP/EP/USP |
DMF v postopku |
59729-32-7 |
Kariprazin hidroklorid | Notranja | DMF | 1083076-69-0 |
Lasmiditan Succinate | Notranja | DMF | 439239-92-6 |
Luliconazol | Notranja | DMF | 187164-19-8 |
Apalutami | Notranja | DMF | 956104-40-8 |
Tadalafil | CP/EP/USP | Pod raziskavo in razvoj | 171596-29-5 |
Replagolix | Notranja | DMF v postopku | 737789-87-6 |
Ruxolitinib fosfat |
Notranja |
DMF v postopku |
1092939-17-7 |
Abemaciclib |
Notranja |
Pod raziskavo in razvoj |
1231929-97-7 |
Phloroglucinol | CP/EP | DMF | 108-73-6 |
1,3,5-trimetoksibenzen |
CP/Inter |
GMP |
621-23-8 |
Ursodeoksiholična kislina | EP/USP/JP | Pod raziskavo in razvoj | 128-13-2 |
Tauroursodeoksiholična kislina |
Notranja |
Pod raziskavo in razvoj |
14605-22-2 |
Holesterol |
CP/EP/USP/JP |
Pod raziskavo in razvoj |
57-88-5 |
Omega-3-kislinski etilni etri 90 |
EP/USP |
DMF v postopku |
—— |
Trigliceridi srednje verige |
CP/USP/EP |
DMF |
—— |
Benzalkonijev klorid |
USP/EP/JP |
CEP v postopku |
8001-54-5 |
Oljčno olje (za injiciranje) |
CP/USP/EP/JP |
DMF v postopku |
8001-25-0 |
Jajčni fosfolipidi (za injiciranje) |
CP/USP/EP |
DMF |
93685-90-6 |
Prigrizek |
Notranja |
DMF v postopku |
203787-91-1 |
Testosteron ima specifikacije CP, EP in USP. CEP, DMF, WC, FDA na voljo..
Testosteron undekanoat ima na voljo specifikacijo CP. TP in DMF v prijavi.
Testosteron Cypionate ima na voljo specifikacijo USP. TP in DMF v vložitvi.
DHEA (prasteron) ima FP in lastno specifikacijo. Na voljo sta DMF in WC.
Gestoden ima specifikacijo CP in EP. DMF, GMP na voljo.
Etinilestradiol ima specifikacije USP, EP in CP. Na voljo sta DMF in GMP.